Citation: | XU Yi, YU Feng, LIU Yun. Role of non-coding RNA in pulmonary arterial hypertension[J]. Journal of China Pharmaceutical University, 2019, 50(1): 107-112. DOI: 10.11665/j.issn.1000-5048.20190115 |
[1] |
Zhu N,Welch CL,Wang J,et al.Rare variants in SOX17 are associated with pulmonary arterial hypertension with congenital heart disease[J].Genome Med,2018,10(1):56.
|
[2] |
Berger RM,Beghetti M,Humpl T,et al.Clinical features of paediatric pulmonary hypertension:a registry study[J].Lancet,2012,379(9815):537-546.
|
[3] |
Palazzini M,Dardi F,Manes A,et al.Pulmonary hypertension due to left heart disease:analysis of survival according to the haemodynamic classification of the 2015 ESC/ERS guidelines and insights for future changes[J].Eur J Heart Fail,2018,20(2):248-255.
|
[4] |
Kim Y,Kim VN.MicroRNA factory:RISC assembly from precursor microRNAs[J].Mol cell,2012,46(4):384-386.
|
[5] |
Quinn JJ,Chang HY.Unique features of long non-coding RNA biogenesis and function[J].Nat Rev Genet,2016,17(1):47-62.
|
[6] |
Guttman M,Rinn JL.Modular regulatory principles of large non-coding RNAs[J].Nature,2012,482(7385):339-346.
|
[7] |
Cech TR,Steitz JA.The noncoding RNA revolution-trashing old rules to forge new ones[J].Cell,2014,157(1):77-94.
|
[8] |
Schuergers N,Mullineaux CW,Wilde A.Cyanobacteria in motion[J].Curr Opin Plant Biol,2017,37:109-115.
|
[9] |
Kiss T.Small nucleolar RNAs:an abundant group of noncoding RNAs with diverse cellular functions[J].Cell,2002,109(2):145-148.
|
[10] |
Lagos-Quintana M,Rauhut R,Lendeckel W,et al.Identification of novel genes coding for small expressed RNAs[J].Science,2001,294(5543):853-858.
|
[11] |
Flynt AS,Lai EC.Biological principles of microRNA-mediated regulation:shared themes amid diversity[J].Nat Rev Genet,2008,9(11):831-842.
|
[12] |
Huang B,Li H,Huang L,et al.Clinical significance of microRNA 138 and cyclin D3 in hepatocellular carcinoma[J].J Surg Res,2015,193(2):718-723.
|
[13] |
Gou D,Ramchandran R,Peng X,et al.miR-210 has an antiapoptotic effect in pulmonary artery smooth muscle cells during hypoxia[J].Am J Physiol Lung Cell Mol Physiol,2012,303(8):L682-691.
|
[14] |
De la Garza MM,Cumpian AM,Daliri S,et al.COPD-Type lung inflammation promotes K-ras mutant lung cancer through epithelial HIF-1alpha mediated tumor angiogenesis and proliferation[J].Oncotarget,2018,9(68):32972-32983.
|
[15] |
Liu JJ,Zhang H,Xing F,et al.MicroRNA138 promotes proliferation and suppresses mitochondrial depolarization in human pulmonary artery smooth muscle cells through targeting TASK1[J].Mol Med Rep,2018,17(2):3021-3027.
|
[16] |
Yue J, Guan J, Wang X, et al. MicroRNA-206 is involved in hypoxia-induced pulmonary hypertension through targeting of the HIF-1alpha/Fhl-1 pathway[J].Lab Invest,2013,93(7):748-759.
|
[17] |
Guo L,Qiu Z,Wei L,et al.The microRNA-328 regulates hypoxic pulmonary hypertension by targeting at insulin growth factor 1 receptor and L-type calcium channel-alpha1C[J].Hypertension,2012,59(5):1006-1013.
|
[18] |
Sawada H,Saito T,Nickel NP,et al.Reduced BMPR2 expression induces GM-CSF translation and macrophage recruitment in humans and mice to exacerbate pulmonary hypertension[J].J Exp Med,2014,211(2):263-280.
|
[19] |
Abbasi Y,Jabbari J,Jabbari R,et al.Exome data clouds the pathogenicity of genetic variants in pulmonary arterial hypertension[J].Mol Genet Genomic Med,2018,6(5):835-844.
|
[20] |
Pickworth J,Rothman A,Iremonger J,et al.Differential IL-1 signaling induced by BMPR2 deficiency drives pulmonary vascular remodeling[J].Pulm Circ,2017,7(4):768-776.
|
[21] |
Brock M,Trenkmann M,Gay RE,et al.Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway[J].Circ Res,2009,104(10):1184-1191.
|
[22] |
Sosa Iglesias V,Giuranno L,Dubois LJ,et al.Drug resistance in non-small cell lung cancer:a potential for NOTCH targeting[J].Front Oncol,2018,8:267.
|
[23] |
Li X,Zhang X,Leathers R,et al.Notch3 signaling promotes the development of pulmonary arterial hypertension[J].Nat Med,2009,15(11):1289-1297.
|
[24] |
Wang D,Zhang H,Li M,et al.MicroRNA-124 controls the proliferative,migratory,and inflammatory phenotype of pulmonary vascular fibroblasts[J].Circ Res,2014,114(1):67-78.
|
[25] |
Sessa R,Hata A.Role of microRNAs in lung development and pulmonary diseases[J].Pulm Circ,2013,3(2):315-328.
|
[26] |
Yu H,Xu M,Dong Y,et al.1,25(OH)2D3 attenuates pulmonary arterial hypertension via microRNA-204 mediated Tgfbr2/Smad signaling[J].Exp Cell Res,2018,362(2):311-323.
|
[27] |
Wang FE,Zhang C,Maminishkis A,et al.MicroRNA-204/211 alters epithelial physiology[J].FASEB J,2010,24(5):1552-1571.
|
[28] |
Zhang Y,Zhang R,Luo G,et al.Long noncoding RNA SNHG1 promotes cell proliferation through PI3K/AKT signaling pathway in pancreatic ductal adenocarcinoma[J].J Cancer,2018,9(15):2713-2722.
|
[29] |
Khorkova O,Hsiao J,Wahlestedt C.Basic biology and therapeutic implications of lncRNA[J].Adv Drug Deliv Rev,2015,87:15-24.
|
[30] |
Johnsson P,Lipovich L,Grander D,et al.Evolutionary conservation of long non-coding RNAs,sequence,structure,function[J].Biochim Biophys Acta,2014,1840(3):1063-1071.
|
[31] |
Deng L,Bradshaw AC,Baker AH.Role of noncoding RNA in vascular remodelling[J].Curr Opin Lipidol,2016,27(5):439-448.
|
[32] |
Zhang L,Wang Q,Wang F,et al.LncRNA LINC01446 promotes glioblastoma progression by modulating miR-489-3p/TPT1 axis[J].Biochem Biophys Res Commun,2018,503(3):1484-1490.
|
[33] |
Zhuo Y, Zeng Q, Zhang P, et al. Functional polymorphism of lncRNA MALAT1 contributes to pulmonary arterial hypertension susceptibility in Chinese people[J].Clin Chem Lab Med,2017,55(1):38-46.
|
[34] |
Michalik KM,You X,Manavski Y,et al.Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth[J].Circ Res,2014,114(9):1389-1397.
|
[35] |
Zhu B,Gong Y,Yan G,et al.Down-regulation of lncRNA MEG3 promotes hypoxia-induced human pulmonary artery smooth muscle cell proliferation and migration via repressing PTEN by sponging miR-21[J].Biochem Biophys Res Commun,2018,495(3):2125-2132.
|
[36] |
Leisegang MS,Fork C,Josipovic I,et al.Long noncoding RNA MANTIS facilitates endothelial angiogenic function[J].Circulation,2017,136(1):65-79.
|
[37] |
Wang J,Zhu MC,Kalionis B,et al.Characteristics of circular RNA expression in lung tissues from mice with hypoxiainduced pulmonary hypertension[J].Int J Mol Med,2018,42(3):1353-1366.
|
[38] |
Legnini I,Di Timoteo G,Rossi F,et al.Circ-ZNF609 is a circular rna that can be translated and functions in myogenesis[J].Mol Cell,2017,66(1):22-37.
|
[39] |
Shan K,Liu C,Liu BH,et al.Circular noncoding RNA HIPK3 mediates retinal vascular dysfunction in diabetes mellitus[J].Circulation,2017,136(17):1629-1642.
|
[40] |
Saintigny P,Mitani Y,Pytynia KB,et al.Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma:implications for targeted therapy[J].Cancer,2018,124(18):3693-3705.
|
[41] |
Ding Q,Chen Y,Dong S,et al.Astrocyte elevated gene-1 is overexpressed in non-small-cell lung cancer and associated with increased tumour angiogenesis[J].Interact Cardiovasc Thorac Surg,2018,26(3):395-401.
|
[42] |
Wang K,Long B,Liu F,et al.A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223[J].Eur Heart J,2016,37(33):2602-2611.
|
[43] |
Wu Y, Tang TT, Zhu QH, et al. Mechanisms of miR-29a in migration and invasion of breast cancer MCF-7 cells in vitro[J].J China Pharm Univ(中国药科大学学报),2018,49(3):348-353.
|